Feasibility Study Analysis on Snack Business (Fried Chicken Dumplings)
Zentrum Economic, Business, Management, Accounting Research · 2026
DOI: 10.69657/5zyqk102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zentrum Economic, Business, Management, Accounting Research, 2026. Verfasst von Nabila Putri Mulyati und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-SA 4.0).
Abstract (Originalsprache)
The purpose of this research is to determine the feasibility of business development that will be carried out by student businesses accountancy. The research method used involves analyzing various aspects of business feasibility studies, namely consumer needs aspects, market condition aspects, legal aspects, technical aspects, financial aspects, as well as economic and social aspects. The results of the analysis of each aspect show positive results, stating that the business development carried out by cemal-cemilin is worthy of implementation. The conclusion of this research is that there are business The cemal-cemilin (fried chicken dumplings) are good can compete in a way healthy. must own quality and taste of facet need desired customers good taste from chicken fried dumplings. So that consumers interested with our products sell.
Zitieren
APA
Mulyati, N. P., Tasya, B. G. N., Alfauzi, D., & Wulandari, S. (2026). Feasibility Study Analysis on Snack Business (Fried Chicken Dumplings). Zentrum Economic, Business, Management, Accounting Research. https://doi.org/10.69657/5zyqk102
Vancouver
Mulyati NP, Tasya BGN, Alfauzi D, Wulandari S. Feasibility Study Analysis on Snack Business (Fried Chicken Dumplings). Zentrum Economic, Business, Management, Accounting Research. 2026. doi:10.69657/5zyqk102
BibTeX
@article{Mulyati2026,
author = {Mulyati, Nabila Putri and Tasya, Baiq Ghina Nabila and Alfauzi, Deni and Wulandari, Suciati},
title = {Feasibility Study Analysis on Snack Business (Fried Chicken Dumplings)},
journal = {Zentrum Economic, Business, Management, Accounting Research},
year = {2026},
doi = {10.69657/5zyqk102}
}
EUVIMED